http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015228829-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95eaed79dec59391549e8016815b3a8f |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-97 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 |
| filingDate | 2014-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d19653906b185334f785cb306ca69f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a40db81f25c5b6c73cdab837b6eca38 |
| publicationDate | 2015-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2015228829-A |
| titleOfInvention | How to select antibacterial agents |
| abstract | An object of the present invention is to provide a method for selecting an antibacterial agent that is effective in preventing or improving the deterioration of the skin condition associated with the menstrual cycle. In the system, the expression level of the antimicrobial peptide in the presence of the test substance and progesterone is measured and the expression level of the antimicrobial peptide in the presence of only progesterone, and the expression level of the antimicrobial peptide in the presence of the test substance and progesterone is A method for selecting an antibacterial agent, wherein the test substance is selected as an antibacterial agent when the expression level of the antibacterial peptide is exceeded in the presence of only progesterone. The antibacterial peptide is preferably hBD-3, and the expression level of the antibacterial peptide is preferably the expression level of hBD-3 mRNA. [Selection] Figure 1 |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021215532-A1 |
| priorityDate | 2014-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 350.